Premium
Induction of ovulation with human pituitary gonadotropin: Twelve years’ experience
Author(s) -
Kovacs Gabor T.,
Dennis Peter M.,
Shelton Rhonda J.,
Outch Ken H.,
McLean Robert A.,
Healy David L.,
Burger Henry G.
Publication year - 1984
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1984.tb108421.x
Subject(s) - pregnanediol , anovulation , ovulation induction , ovulation , human chorionic gonadotropin , gonadotropin , medicine , gynecology , hormone , insulin resistance , polycystic ovary , insulin
Twelve years’ experience in the therapeutic use of human pituitary gonadotrophins in 74 patients with anovulation is reviewed. Of these 74 patients, 54 conceived on at least one occasion. A new development, the use of radioimmunossays for oestrone‐3‐glucuronide and pregnanediol‐3‐glucuronide to monitor responses, has been shown to be as effective as the more laborious chemical methods which were previously used. The adoption of radioimunossay monitoring allows the simultaneous treatment of up to five patients, and will markedly reduce existing waiting lists for this treatment.